Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia, Moderate”

500 trials

Showing 20 of 500 results

Testing effectiveness (Phase 2)Ended earlyNCT01712074
What this trial is testing

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

Who this might be right for
Alzheimer's Disease
Pfizer 186
Testing effectiveness (Phase 2)Study completedNCT01266525
What this trial is testing

Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

Who this might be right for
Dementia Alzheimer's Type
Sanofi 291
Testing effectiveness (Phase 2)Study completedNCT00224497
What this trial is testing

A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 380
Large-scale testing (Phase 3)Ended earlyNCT02327182
What this trial is testing

Safety Study of MT-4666 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Tanabe Pharma Corporation 117
Testing effectiveness (Phase 2)Study completedNCT00359944
What this trial is testing

Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sumitomo Pharma America, Inc. 171
Testing effectiveness (Phase 2)Study completedNCT03560245
What this trial is testing

Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine

Who this might be right for
Alzheimer Disease
Neurotrope Bioscience, Inc. 108
Early research (Phase 1)Study completedNCT02859207
What this trial is testing

Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects

Who this might be right for
Early Alzheimer's Disease
Eisai Inc. 32
Large-scale testing (Phase 3)Ended earlyNCT00679627
What this trial is testing

Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Janssen Research & Development, LLC 2,051
Early research (Phase 1)Study completedNCT00100282
What this trial is testing

Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
PRAECIS Pharmaceuticals Inc. 125
Large-scale testing (Phase 3)Ended earlyNCT01969123
What this trial is testing

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
FORUM Pharmaceuticals Inc 474
Testing effectiveness (Phase 2)Ended earlyNCT01766336
What this trial is testing

A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 296
Testing effectiveness (Phase 2)Ended earlyNCT00087724
What this trial is testing

Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Astellas Pharma Inc 510
Early research (Phase 1)Study completedNCT01168245
What this trial is testing

TMS Stimulation and Cognitive Training in Alzheimer Patients

Who this might be right for
Alzheimer DiseaseMild to Moderate
Neuronix Ltd 15
Early research (Phase 1)Study completedNCT03277573
What this trial is testing

Salsalate in Patients Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Adam Boxer 40
Testing effectiveness (Phase 2)Study completedNCT00884507
What this trial is testing

RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 389
Testing effectiveness (Phase 2)Study completedNCT03402503
What this trial is testing

Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
IntelGenx Corp. 52
Large-scale testing (Phase 3)Looking for participantsNCT06702124
What this trial is testing

Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
I.R.C.C.S. Fondazione Santa Lucia 348
Testing effectiveness (Phase 2)Study completedNCT01761227
What this trial is testing

Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia

Who this might be right for
Vascular Dementia
Dongzhimen Hospital, Beijing 240
Not applicableNo Longer AvailableNCT06961760
What this trial is testing

Expanded Access Program for CT1812 (Zervimesine)

Who this might be right for
Dementia With Lewy Bodies
Cognition Therapeutics
Testing effectiveness (Phase 2)Study completedNCT00479557
What this trial is testing

Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 86
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation